Theriva Biologics Past Performance

How has Theriva Biologics performed over the past 5 years?

Past Performance Score

0/6

Past Performance Score 0/6

  • Quality Earnings

  • Growing Profit Margin

  • Earnings Trend

  • Accelerating Growth

  • Earnings vs Industry

  • High ROE


5.0%

Historical annual earnings growth

Earnings and Revenue History

Quality Earnings: TOVX is currently unprofitable.

Growing Profit Margin: TOVX is currently unprofitable.


Past Earnings Growth Analysis

Earnings Trend: TOVX is unprofitable, but has reduced losses over the past 5 years at a rate of 5% per year.

Accelerating Growth: Unable to compare TOVX's earnings growth over the past year to its 5-year average as it is currently unprofitable

Earnings vs Industry: TOVX is unprofitable, making it difficult to compare its past year earnings growth to the Biotechs industry (53%).


Return on Equity

High ROE: TOVX has a negative Return on Equity (-33.29%), as it is currently unprofitable.


Return on Assets


Return on Capital Employed


Discover strong past performing companies